163 related articles for article (PubMed ID: 1667792)
1. IgM-antibody response to hepatitis C virus antigens in acute and chronic post-transfusion non-A, non-B hepatitis.
Chau KH; Dawson GJ; Mushahwar IK; Gutierrez RA; Johnson RG; Lesniewski RR; Mattsson L; Weiland O
J Virol Methods; 1991 Dec; 35(3):343-52. PubMed ID: 1667792
[TBL] [Abstract][Full Text] [Related]
2. IgM antibody response in acute hepatitis C viral infection.
Clemens JM; Taskar S; Chau K; Vallari D; Shih JW; Alter HJ; Schleicher JB; Mimms LT
Blood; 1992 Jan; 79(1):169-72. PubMed ID: 1309424
[TBL] [Abstract][Full Text] [Related]
3. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
Nagayama R; Miyake K; Tsuda F; Okamoto H
J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
[TBL] [Abstract][Full Text] [Related]
4. IgM anti-C100-3 antibodies in hepatitis C virus infection.
Sansonno D; Gatti P
Int J Clin Lab Res; 1992; 21(3):267-8. PubMed ID: 1317226
[No Abstract] [Full Text] [Related]
5. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
[TBL] [Abstract][Full Text] [Related]
6. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
[TBL] [Abstract][Full Text] [Related]
7. Anti-HCV immunoglobulin M antibody in patients with acute and fulminant hepatitis C.
Akbar SM; Onji M; Horiike N; Ohta Y
Gastroenterol Jpn; 1993 May; 28 Suppl 5():71-5. PubMed ID: 7689511
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of an anti-HCV core peptide ELISA.
Bresters D; Reesink HW; Cuypers HT; Jansen PL; Mauser-Bunschoten EP; van der Poel CL; Lelie PN
J Med Virol; 1992 Jul; 37(3):187-91. PubMed ID: 1279109
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma.
Watanabe Y; Harada S; Saito I; Miyamura T
Int J Cancer; 1991 May; 48(3):340-3. PubMed ID: 1710205
[TBL] [Abstract][Full Text] [Related]
10. Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C.
Brillanti S; Masci C; Ricci P; Miglioli M; Barbara L
Hepatology; 1992 Jun; 15(6):998-1001. PubMed ID: 1317344
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to recombinant and synthetic peptides derived from the hepatitis C virus genome in long-term-studied patients with posttransfusion hepatitis C.
Mattsson L; Gutierrez RA; Dawson GJ; Lesniewski RR; Mushahwar LK; Weiland O
Scand J Gastroenterol; 1991 Dec; 26(12):1257-62. PubMed ID: 1722348
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.
Chien DY; Choo QL; Tabrizi A; Kuo C; McFarland J; Berger K; Lee C; Shuster JR; Nguyen T; Moyer DL
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10011-5. PubMed ID: 1279666
[TBL] [Abstract][Full Text] [Related]
13. IgM and IgA antibodies generated against hepatitis C virus core antigen in patients with acute and chronic HCV infection.
Sato S; Fujiyama S; Tanaka M; Goto M; Taura Y; Kawano S; Sato T; Yasuo H
Dig Dis Sci; 1994 Sep; 39(9):2022-31. PubMed ID: 7521823
[TBL] [Abstract][Full Text] [Related]
14. Improved serodiagnosis of non-A, non-B hepatitis by an assay detecting antibody to hepatitis C virus core antigen.
Katayama T; Mazda T; Kikuchi S; Harada S; Matsuura Y; Chiba J; Ohba H; Saito I; Miyamura T
Hepatology; 1992 Mar; 15(3):391-4. PubMed ID: 1371981
[TBL] [Abstract][Full Text] [Related]
15. Is the detection of anti-hepatitis C virus core IgM influenced by the presence of serum rheumatoid factor?
Pawlotsky JM; Remire J; Darthuy F; Intrator L; Udin L; Dhumeaux D; Duval J
J Med Virol; 1995 Jan; 45(1):68-70. PubMed ID: 7536232
[TBL] [Abstract][Full Text] [Related]
16. Anti-HCV immunoglobulin M antibody in patients with hepatitis C.
Kikuchi T; Onji M; Michitaka K; Saito I; Miyamura T; Ohta Y
J Gastroenterol Hepatol; 1992; 7(3):246-8. PubMed ID: 1319222
[TBL] [Abstract][Full Text] [Related]
17. Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay.
Gish RG; Warmerdam MT; Zeldis JB; Keeffe EB; Nakazato P; Lim J; Cox K; Kuramoto IK; Fry KE; Yarbough PO
Viral Immunol; 1993; 6(1):49-54. PubMed ID: 7682814
[TBL] [Abstract][Full Text] [Related]
18. IgM antibody response to the hepatitis C virus core protein in intravenous drug users.
Toniutto P; Falleti E; Gasparini V; Fabris C; Tisminetzky SG; Lombardelli T; Pacco P; Satta A; Pirisi M
Diagn Microbiol Infect Dis; 1999 Feb; 33(2):69-73. PubMed ID: 10091028
[TBL] [Abstract][Full Text] [Related]
19. [Second generation hepatitis-C virus test and polymerase chain reaction in anti-C 100 negative patients with chronic non-A, non-B hepatitis].
Zala G; Havelka J; Wicki AN; Joller-Jemelka HI; Meier B; Schmid M; Bühler H
Schweiz Med Wochenschr; 1992 Mar; 122(11):363-8. PubMed ID: 1313601
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of specific detection of anti-HCV IgM core antibodies.
Kapprell HP; Michel G; Hampl H; Bonino F; Esteban JI
J Virol Methods; 1996 May; 59(1-2):121-6. PubMed ID: 8793838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
